Fisher (James) & Sons PLC
23 June 2005
James Fisher and Sons Public Limited Company ('the Company')
Directors Interest in Shares
On 22 June 2005 the Company granted options to the executive directors of the
Company under the new executive share option scheme (2005) which was approved by
shareholders on 29th April 2005 and the inland revenue on 17th June 2005. The
options have been granted at a price of 327p per share being the average middle
market price of a share over the three dealing days immediately preceding the
date of grant. The award is granted subject to the performance conditions
stipulated in the scheme rules and the option is exercisable from 22 June 2008
to 22 June 2015 assuming that the performance conditions are met.
Details of the award under the scheme to each director and the number of options
they hold following this grant are set out below:
Options Granted Total Number of Ordinary
over Ordinary shares Shares under Option
T C Harris 67,278 192,560
N P Henry 40,367 44,739
I M Serjent 33,945 129,368
M J Shields 33,028 136,857
No consideration was paid for the grant of these options.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.